The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.

Adrenergic beta-Agonists/pharmacology,therapeutic use Adult Aerosols Amino Alcohols/pharmacology,therapeutic use Bronchi/drug effects Bronchodilator Agents/administration & dosage,adverse effects,pharmacology,therapeutic use Catechols/administration & dosage,therapeutic use Dose-Response Relationship, Drug Heart Rate/drug effects Humans In Vitro Techniques Infant, Newborn Isoproterenol/pharmacology,therapeutic use Lung Diseases/drug therapy Methanol/administration & dosage,therapeutic use Middle Aged Muscle Contraction/drug effects Muscle, Smooth/drug effects Piperidines/administration & dosage,therapeutic use Placebos Respiration/drug effects Spirometry Stimulation, Chemical Time Factors

Adrenergic beta-Agonists Aerosols Amino Alcohols Bronchodilator Agents Catechols Piperidines Placebos rimiterol Isoproterenol Methanol